We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-2.52%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$196M
AUM Growth
-$77.5M
(-28%)
Cap. Flow
-$72.9M
Cap. Flow
% of AUM
-37.24%
Top 10 Holdings %
Top 10 Hldgs %
56.4%
Holding
63
New
21
Increased
5
Reduced
15
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$16.1M |
| 2 |
Medtronic
MDT
|
+$6.07M |
| 3 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$4.21M |
| 4 |
Abbott
ABT
|
+$4.16M |
| 5 |
Cardinal Health
CAH
|
+$2.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$12.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$10.9M |
| 3 |
Eli Lilly
LLY
|
+$10.1M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$9.65M |
| 5 |
AGN
Allergan plc
AGN
|
+$9.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.02% |
| 2 | Industrials | 1.3% |
| 3 | Consumer Discretionary | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
SCYNEXIS
SCYX
$35.3M
| – | – |
-3,557
| Closed | -$1.15M |
|
|
SGMO
52
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| – | – |
-395,496
| Closed | -$2.39M |
|
53
PUT
Sarepta Therapeutics
SRPT
$1.62B
| – | – |
-29,000
| Closed | -$566K |
|
54
United Therapeutics
UTHR
$26.4B
| – | – |
-77,317
| Closed | -$8.62M |
|
|
RAD
55
DELISTED
Rite Aid Corporation
RAD
| – | – |
-20,639
| Closed | -$3.36M |
|
|
AGRX
56
DELISTED
Agile Therapeutics
AGRX
| – | – |
-83
| Closed | -$1.03M |
|
|
AGN
57
DELISTED
Allergan plc
AGN
| – | – |
-35,937
| Closed | -$9.63M |
|
|
VSI
58
DELISTED
Vitamin Shoppe Inc.
VSI
| – | – |
-224,668
| Closed | -$6.96M |
|
|
RXDX
59
DELISTED
Ignyta, Inc.
RXDX
| – | – |
-805,327
| Closed | -$5.45M |
|
|
LDRH
60
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| – | – |
-144,033
| Closed | -$3.67M |
|
|
CPXX
61
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| – | – |
-243,475
| Closed | -$2.69M |
|
|
BEAT
62
DELISTED
BioTelemetry, Inc.
BEAT
| – | – |
-413,649
| Closed | -$4.83M |
|
|
SHPG
63
DELISTED
Shire pic
SHPG
| – | – |
-63,411
| Closed | -$10.9M |
|
Similar funds
GUB
KLI
JA
WIC
AAM
TCM
CA
SAM
Sio Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Sio Capital Management held 63 positions worth $196M, down 28% from $273M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Sio Capital Management withdrew a net $72.9M in Q2 2016, closing 19 positions and reducing 15 holdings. Its most notable exit was Shire pic, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 74% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Sio Capital Management opened a new position in Biogen worth $14.8M.
- Sio Capital Management's largest Q2 2016 buy was Biogen: 61,000 shares worth $14.8M.
- Sio Capital Management added most to Cardinal Health in Q2 2016, an estimated $2.85M increase.
- Sio Capital Management's biggest Q2 2016 reduction was McKesson, cutting an estimated $12.9M.
- Sio Capital Management fully exited Shire pic in Q2 2016, selling an estimated $10.9M.
- Sio Capital Management's ten largest holdings make up 56% of its $196M portfolio in Q2 2016.
- Sio Capital Management opened 21 new positions and closed 19 in Q2 2016.
- Sio Capital Management's portfolio value fell 28% quarter-over-quarter to $196M.
Based on Sio Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.